Pneumonias and immunosuppression;Pneumonien bei immunsuppression

Internist

Volumn 48, Issue 5, 2007, Pages 507-518

  Dalhoff, K ^a   Marxsen, J ^b   Steinhoff, J ^b  

^a Medizinische Klinik II   (Germany)

^b Medizinische Klinik I   (Germany)

Author keywords

Antimicrobial therapy; Bronchoscopy; Immunodeficiency; Immunosuppression; Pneumonia

Indexed keywords

ALEMTUZUMAB; AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B LIPID COMPLEX; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CASPOFUNGIN; CEPHALOSPORIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; GANCICLOVIR; LINEZOLID; MACROLIDE; OXACILLIN; PENTAMIDINE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; RITUXIMAB; VALGANCICLOVIR; VORICONAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS FUMIGATUS; ASPIRATION BIOPSY; BACTERIAL PNEUMONIA; BLOOD ANALYSIS; BRONCHOSCOPY; CANCER CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCUS NEOFORMANS; CYTOMEGALOVIRUS; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LEGIONELLA; LUNG ASPERGILLOSIS; LUNG BIOPSY; LUNG LAVAGE; MORAXELLA CATARRHALIS; MYCOBACTERIUM AVIUM; NEUTROPENIA; ORGAN TRANSPLANTATION; PATHOGENESIS; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; POLYMERASE CHAIN REACTION; SPUTUM ANALYSIS; STAPHYLOCOCCUS AUREUS; URINALYSIS; VIRUS PNEUMONIA;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ALGORITHMS; ANTI-INFECTIVE AGENTS; BACTERIOLOGICAL TECHNIQUES; BIOPSY; BRONCHOSCOPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG; OPPORTUNISTIC INFECTIONS; PNEUMONIA; PNEUMONIA, BACTERIAL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34248333769     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-007-1838-5     Document Type: Article

References (54)

1. Deutsche Stiftung Organtransplantation (2006) Organspende und Transplantation in Deutschland 2005. DSO, Neu-Isenburg, http://www.dso.de
2. Deutsches Register für Stammzelltransplantationen (2006) DRST-Jahresbericht 2005. DRST, Essen, Ulm http://www.drst.de
3. Robert-Koch Institut (2006) Epidemiologisches Bulletin 31.10.2006. RKI, Berlin, http://www.rki.de
4. Shorr AF, Susla GM, O'Grady NP( 2004) Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes. Chest 125: 260-271
5. Martin SI, Marty FM, Fiumara K (2006) Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis 43: 16-24
6. Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338: 1741-1751
7. Vernovsky I, Dellaripa PF (2000) Pneumocystis carinii pneumonia prophylaxis in patients with rheumatic diseases undergoing immunosuppressive therapy. J Clin Rheumatol 6: 94-101
8. Hamilton CD (2005) Immunosuppression related to collagen vascular disease or its treatment. Proc Am Thorac Soc 2: 456-460
9. Bridgen ML, Patullo AL (1999) Prevention and management of overwhelming postsplenectomy infection - an update. Crit Care Med 27: 836-842
10. Christensen D, Feldman C, Rossi P et al. (2005) HIV infection does not influence clinical outcomes in bacterial community-acquired pneumonia. Clin Infect Dis 41: 554-556
11. Acrasoy SM, Kotloff RM (1999) Lung transplantation. N Engl J Med 14: 1081-1091
12. Carratala J, Roson B, Fernandez-Sevilla A et al. (1998) Bacteremic pneumonia in neutropenic patients with cancer. Arch Intern Med 158: 868-872
13. Knirsch CA, Jakob K, Schoonmaker D et al. (2000) An outbreak of Legionella micdadei pneumonia in transplant patients. Am J Med 108: 290-295
14. Husain S, McCurry C, Dauber J et al. (2002) Nocardia infection in lung transplant recipients. J Heart Lung Transplant 21: 354-359
15. Queipo JA, Broseta E, Santos M et al. (2003) Mycobacterial infection in a series of 1261 renal transplant recipients. Clin Microbiol Infect 9: 518-525
16. Subira M, Martino R, Rovira M et al (2003) Clinical applicability of the new EORTC/MSG classification for invasive pulmonary aspergillosis in patients with hematological malignancies and autopsy-confirmed invasive aspergillosis. Ann Hematol 82: 80-82
17. Westney GE, Kesten S, DeHoyos A et al. (1996) Aspergillus infection in single and double lung transplant recipients. Transplantation 61: 915-919
18. Sepkowitz KA, Brown AE, Armstrong D (1995) Pneumocystis carinii pneumonia without AIDS: more patients, same risk. Arch Intern Med 155: 1125-1128
19. Thomas CF, Limper AII (1998) Pneumocystis pneumonia: clinical presentation and diagnosis in patients with and without AIDS. Semin Respir Infect 13: 289-295
20. Egan JJ, Lomax J, Barber L et al. (1998) Preemptive treatment for the prevention of cytomegalovirus disease in lung and heart transplant recipients. Transplantation 65: 747-752
21. Singh N (2005) Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis 40: 704-708
22. Afessa B, Green W, Chiao J et al. (1998) Pulmonary complications of HIV-infection. Chest 113: 1225-1229
23. Ison MG (2006) Adenovirus infections in transplant recipients. Clin Infect Dis 43: 331-339
24. Kaiser L, Aubert JD, Pache JC et al. (2006) Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med 174: 1392-1399
25. Koch A., Kothe H, Braun J et al. (1998) Inzidenz bakterieller Pneumonien bei HIV-positiven Patienten unter Co-trimoxazol oder Pentamidin. Pneumologie 52: 614-621
26. Mayaud C, Cadranel J (2001) AIDS and the lung in a changing world. Thorax 56: 423-426
27. Logan PM, Primack SL, Staples C (1995) Acute lung disease in the immunocompromised host. Diagnostic accuracy of the chest radiograph. Chest 108: 1283-1287
28. Maschmeyer G, Beinert T, Buchheidt D et al. (2003) Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients - Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol (Suppl 2) 82: S118-S126
29. Heussel CP, Kauczor HU, Heussel GE et al. (1999) Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 17: 796-805
30. Rano A, Agusti C, Jimenez P et al. (2001) Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 56: 379-387
31. Horvath J, Dummer S (1996) The use of respiratory tract cultures in the diagnosis of invasive aspergillosis. Am J Med 100: 171-178
32. Ewig S, Tuschy P, Fätkenheuer G (2002) Diagnostik und Therapie der Legionellenpneumonie. Pneumologie 56: 695-703
33. Bohme A, Ruhnke M, Buchheidt D (2003) Treatment of fungal infections in hematology and oncology - guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol (Suppl 2) 82: S133-140
34. Maertens J, Theunissen K, Verhoef G et al. (2005) Galactomanna and CT-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection. Clin Infect Dis 41: 1242-1250
35. Pfeiffer CD, Fine JP, Safdar N (2006). Diagnosis of invasive aspergillosis using a galactomannan assay: a metaanalysis. Clin Infect Dis 42: 1417-1427
36. Humar A, Gregson D, Caliendo AM et al. (1999) Clinical utility of quantitative cytomegalovirus viral load determination for pedicting cytomegalovirus disease in liver transplant recipients. Transplantation 68: 1305-1311
37. Honda J, Yonemitsu J, Kitajiama H et al. (2001) Clinical utility of capillary polymerase chain reaction for diagnosis of cytomegalovirus pneumonia. Scand J Infect.Dis 33: 702-705
38. Jain P, Sandur S, Meli Y et al. (2004) Role of flexible bronchoscopy in immunocompromised patients with lung infiltrates. Chest 125: 712-722
39. Reichenberger F, Dickenmann M, Binet I et al. (2001) Diagnostic yield of bronchoalveolar lavage following renal transplantation. Transplant Infect Dis 3: 2-7
40. Stover DE, Zaman MB, Hajdu SI et al. (1984) Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med 101: 1-7
41. Klont RR, Mennink-Kersten MA, Verweij PE (2004) Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis 39: 1467-1474
42. Cazzadori A, Di Perri G, Todeschini G (1995) Transbronchial biopsy in the diagnosis of pulmonary infiltrates in immunocompromised patients. Chest 107: 101-106
43. Cadranel J, Gillet-Juvin K, Antoine M et al. (1995) Site-directed bronchoalveolar lavage and transbronchial biopsy in HIV-infected patients with pneumonia. Am J Respir Crit Care Med 152: 1103-1106
44. Wong WP, Stefanec T, Brown K et al. (2002) Role of fine-needle aspirates of focal lung lesions in patients with hematologic malignancies. Chest 121: 527-532
45. White DA, Wong PW, Downey R (2000) The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 161: 723-729
46. Dalhoff K, Ewig S, Höffken G et al. (2002) Empfehlungen zur Diagnostik, Therapie und Prävention von Pneumonien bei erworbenem Immundefizit. Deutsche Gesellschaft für Pneumologie. Pneumologie 56: 807-831
47. Rosenthal EJ et al. (2003) Antibiotika-Empfindlichkeit von Sepsiserregern 2000-2001. Chemother J 12: 71-78
48. Sattler FR, Cowan R, Nielsen DM et al. (1988) Trimethoprim- sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 109: 280-287
49. Bozzette SA, Sattler FR, Chiu J et al. (1990) A controlled trial of early adjunctive treatment with corticosteroids für Pneumocyctis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323: 1451-1457
50. Pareja JG, Garland R, Koziel H (1998) Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia. Chest 113: 1215-1224
51. Munoz P, Rodriguez C, Bouza E (2005) Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 40: 581-587
52. Winston A, Boffito M (2005) The management of HIV-1 protease inhibitor pharmacokinetic interactions. J Antimicrob Chemother 7: 1-5
53. Blanshard C, Benhamou Y, Dohin E et al. (1995) Treatment of AIDS-associated gastrointestinal cytomegalovirus infection with foscarnet and ganciclovir: A randomized comparison. J Infect Dis 172: 622-628
54. Martin DF, Sierra-Madero J, Walmsley S et al.; Valganciclovir Study Group (2002) A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis. N Engl J Med 346: 1119-1126